These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 10459540

  • 21. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y, Sachs DH, Khan A, Sykes M.
    Transplantation; 1996 Feb 15; 61(3):469-77. PubMed ID: 8610363
    [Abstract] [Full Text] [Related]

  • 22. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M.
    Biol Blood Marrow Transplant; 2001 Feb 15; 7(12):646-55. PubMed ID: 11787527
    [Abstract] [Full Text] [Related]

  • 23. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y, Khan A, Sykes M.
    Transplantation; 1996 Feb 15; 61(3):477-85. PubMed ID: 8610364
    [Abstract] [Full Text] [Related]

  • 24. Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.
    Xu H, Ramsey DM, Wu S, Bozulic LD, Ildstad ST.
    Transplantation; 2013 Jan 27; 95(2):301-8. PubMed ID: 23250336
    [Abstract] [Full Text] [Related]

  • 25. Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.
    Xu H, Zhu Z, Huang Y, Bozulic LD, Hussain LR, Yan J, Ildstad ST.
    Transplantation; 2012 Mar 15; 93(5):469-76. PubMed ID: 22228418
    [Abstract] [Full Text] [Related]

  • 26. CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow.
    Xu H, Exner BG, Cramer DE, Tanner MK, Mueller YM, Ildstad ST.
    J Immunol; 2002 Feb 15; 168(4):1636-43. PubMed ID: 11823491
    [Abstract] [Full Text] [Related]

  • 27. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Feb 15; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 28. The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.
    Timrott K, Beetz O, Oldhafer F, Klempnauer J, Vondran FWR, Jäger MD.
    PLoS One; 2020 Feb 15; 15(5):e0233497. PubMed ID: 32442182
    [Abstract] [Full Text] [Related]

  • 29. T-cell depletion of allogeneic bone marrow using anti-alphabetaTCR monoclonal antibody: prevention of graft-versus-host disease without affecting engraftment potential in rats.
    Neipp M, Exner BG, Maru D, Haber M, Gammie JS, Pham SM, Ildstad ST.
    Exp Hematol; 1999 May 15; 27(5):860-7. PubMed ID: 10340402
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
    Barsoukov AA, Moore PF, Storb R, Santos EB, Sandmaier BM.
    Transplantation; 1999 May 27; 67(10):1329-35. PubMed ID: 10360586
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
    Morrissey NJ, Blom D, Ryan CK, Fisher T, Bronsther O, Orloff MS.
    Transpl Immunol; 1999 Mar 27; 7(1):19-25. PubMed ID: 10375074
    [Abstract] [Full Text] [Related]

  • 35. Long-term survival of cardiac xenografts in fully xenogeneic (mouse --> rat) bone marrow chimeras.
    Mohiuddin MM, Qin Y, Qian X, Meng Y, DiSesa VJ.
    Ann Thorac Surg; 2001 Sep 27; 72(3):740-5; discussion 745-6. PubMed ID: 11565651
    [Abstract] [Full Text] [Related]

  • 36. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.
    Lan F, Zeng D, Higuchi M, Higgins JP, Strober S.
    Biol Blood Marrow Transplant; 2003 Jun 27; 9(6):355-63. PubMed ID: 12813443
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
    Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA.
    Xenotransplantation; 2006 May 27; 13(3):224-32. PubMed ID: 16756565
    [Abstract] [Full Text] [Related]

  • 40. Donor-specific tolerance induction in composite tissue allografts.
    Foster RD, Fan L, Neipp M, Kaufman C, McCalmont T, Ascher N, Ildstad S, Anthony JP, Niepp M.
    Am J Surg; 1998 Nov 27; 176(5):418-21. PubMed ID: 9874425
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.